THR-149 dose level 1

DRUG2 trials

Sponsors

ThromboGenics, Oxurion

Conditions

Diabetes MellitusDiabetic Macular EdemaDiabetic Retinopathy

Phase 1

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

CompletedNCT03511898

ThromboGenicsDiabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy

Start: 2018-05-18End: 2019-05-22Updated: 2019-06-13

Phase 2

A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

CompletedNCT04527107

OxurionDiabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy

Start: 2020-07-31End: 2023-11-22Updated: 2023-11-27